Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Sep
5
2017
Should the Australian Patent Office be denying patent eligibility to cDNA inventions? Schwegman, Lundberg & Woessner, P.A.
Mar
7
2022
China Releases Summary of Holdings of the Intellectual Property Tribunal of the Supreme People’s Court (2021) Schwegman, Lundberg & Woessner, P.A.
Apr
12
2011
PTO Issues Final Rule to Implement Prioritized Examination Track (Track I) Schwegman, Lundberg & Woessner, P.A.
Sep
20
2017
So, you are telling me there is a chance? PTAB Finds Anti-Fraud Idea Patentable Schwegman, Lundberg & Woessner, P.A.
Mar
18
2022
China’s Supreme People’s Court Issues Judicial Interpretation of Anti-Unfair Competition Law Schwegman, Lundberg & Woessner, P.A.
Apr
25
2022
China Releases Typical Cases of Intellectual Property Protection by China Customs in 2021 Schwegman, Lundberg & Woessner, P.A.
May
14
2022
China’s State Administration for Market Regulation Releases Typical Cases of Intellectual Property Enforcement for 2021 Schwegman, Lundberg & Woessner, P.A.
Jun
8
2022
China’s Supreme People’s Procuratorate & Ministry of Public Security Jointly Issue Typical Cases Involving Obstructing Epidemic Prevention Including Two Trademark Cases Schwegman, Lundberg & Woessner, P.A.
Sep
15
2011
Myriad Petition For Rehearing Denied Schwegman, Lundberg & Woessner, P.A.
Jun
12
2015
OIP Technologies Inc., v. Amazon.com, Inc, (Fed. Cir. 2012-1696) Schwegman, Lundberg & Woessner, P.A.
Aug
26
2022
Vans Wins Triple Punitive Damages in Chinese Trademark Infringement Case Schwegman, Lundberg & Woessner, P.A.
Jul
13
2015
In re Cuozzo – Still no changes for the claim interpretation standard during inter partes review proceedings Schwegman, Lundberg & Woessner, P.A.
Jul
21
2015
PTAB Guidance on its View of Petitioner Estoppel: Westlake Services v. Credit Acceptance Corp Schwegman, Lundberg & Woessner, P.A.
Oct
31
2022
King Semi Settles Chinese Criminal Trade Secret Case for 60 Million RMB Schwegman, Lundberg & Woessner, P.A.
Nov
4
2022
Five-Year Prison Sentence for Selling $1.27 Million USD of Counterfeit Armani Watches in Shanghai Trademark Case Schwegman, Lundberg & Woessner, P.A.
Dec
31
2022
China to Remove Infringing Pharmaceuticals from Procurement Platforms Schwegman, Lundberg & Woessner, P.A.
Jan
5
2023
5-Month Criminal Detention Sentence for Legal Representative of Chinese IP Agency for Forging TM Documents Schwegman, Lundberg & Woessner, P.A.
May
7
2018
USPTO Posts slides for new examiner training on Section 101 Schwegman, Lundberg & Woessner, P.A.
May
14
2018
PTO Releases Revised Guidance on Compliance with Mayo/Alice Rule Schwegman, Lundberg & Woessner, P.A.
May
22
2018
Ex Parte Stone: The “Disappearing Doctor” Leaves a Medical Device Behind Schwegman, Lundberg & Woessner, P.A.
Apr
4
2023
Intellectual Property Tribunal of China’s Supreme People’s Court Releases ‘Typical Cases’ of 2022 List Schwegman, Lundberg & Woessner, P.A.
Dec
3
2012
Supreme Court Grants Myriad’s Petition for Cert. Schwegman, Lundberg & Woessner, P.A.
Oct
11
2018
Philips Standard of Claim Construction to be Used by PTAB in “AIA Proceedings” Schwegman, Lundberg & Woessner, P.A.
Jan
17
2013
PTO Issues Notice on Improvement in Patent Application Quality – A Very Modest Proposal Schwegman, Lundberg & Woessner, P.A.
Feb
22
2013
Brilliant Instruments v. GuideTech – Doctrine of Equivalents on Review Schwegman, Lundberg & Woessner, P.A.
Mar
5
2019
Hikma and West-Ward v. Vanda – Are Methods of Medical Treatment Patent-Eligible? Schwegman, Lundberg & Woessner, P.A.
Apr
25
2013
America Invents Act (AIA) Patent Trials Differ from Reexamination Schwegman, Lundberg & Woessner, P.A.
May
6
2013
Federal Circuit Patent Litigation Appeal Decision in Versata Software v. SAP Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins